Hemanext Inc. has secured new venture-capital funding ahead of plans to seek U.S. regulatory authorization for a medical device designed to improve blood storage and help patients who depend heavily on donated blood.
Lexington, Mass.-based Hemanext has collected $15 million in new funding and has now raised a total of more than $100 million.
Donated…
Former Trump administration head of financial coverage Tomas Philipson discusses President Trump’s commerce talks with South Korea and Japan, present…
Introduction: For generations, the Wright family has worked and lived on their…
Richard makes debut SAN FRANCISCO – The Warriors‘ acquisition of their three…
FLIGHT CHECK International airlines are increasingly offering mobile apps or…
